Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 17, 2012
Reporting Period: Specific event date of July 17, 2012.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and equity plan adjustments rather than financial performance.
Material Changes
- Equity Plan Amendment: On July 17, 2012, the Board of Directors approved an increase in the number of shares of common stock authorized under the Company's 2010 Equity Participation Plan.
- Share Increase: The authorized share count was raised from 200,000,000 to 300,000,000.
- Shareholder Approval: The increase is scheduled to be submitted for shareholder approval at the next annual meeting of shareholders.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the equity plan amendment.
Investor Verification Checklist
- Verify the date and agenda of the next annual meeting of shareholders to confirm the timeline for the proposed equity plan increase.
- Review the full terms of the 2010 Equity Participation Plan to understand the implications of increasing the authorized share pool by 100,000,000 shares.
- Confirm whether the increase in authorized shares has been approved by shareholders as of the current date.